HQL Net Income Growth
abrdn Life Sciences Investors Shares of Beneficial Interest · Net Income Growth
HQL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported598.85%period ending
HQL TTM Net Income YoY % (-141.05% → 598.85%)
Year-over-year change
High-resolution chart · PNG
HQL net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 598.8511% | |
| 58.7486% | |
| -39.9314% | |
| 230.8785% | |
| 217.1489% | |
| -105.2558% | |
| -146.632% | |
| -121.3624% | |
| -34.1888% | |
| 256.7969% | |
| 1,417.3034% | |
| 225.7328% | |
| 178.1088% | |
| -245.5285% | |
| 47.0012% | |
| 50,627.0067% | |
| -54,887.6382% | |
| 98.1428% | |
| -242.7876% | |
| -77.9705% | |
| -89.5453% | |
| -19.3644% | |
| -98.975% | |
| -99.7929% | |
| -75.8075% | |
| -32.492% | |
| -0.6268% | |
| 141.5025% | |
| 436.1305% | |
| 515.1568% | |
| 33.5055% | |
| -129.7564% | |
| -81.8535% | |
| -65.1679% | |
| 6.8011% | |
| 281.0114% | |
| 166.9021% | |
| 24.6569% | |
| -30.3695% | |
| -55.0847% | |
| -22.9887% | |
| 13.412% | |
| 187.4375% | |
| 488.2952% | |
| 121.618% | |
| 91.8936% | |
| 41.9494% | |
| -15.9716% | |
| -92.6387% | |
| -141.0541% |